🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this trial is to investigate the safety and tolerability of ...
Status
Completed
Location
Multiple Locations
Start Date
2009-06-17
Trial ID
NCT00903786
Treatments Being Tested
This study is designed to evaluate the pharmacokinetics, efficacy, and safe...
Status
Completed
Location
Multiple Locations
Start Date
2012-01
Trial ID
NCT01527006
Treatments Being Tested
The purpose of this study is to explore the maximum tolerated dose of E2007...
Status
Completed
Location
Multiple Locations
Start Date
2009-04
Trial ID
NCT00849212
Treatments Being Tested
The purpose of this study is to evaluate the safety, efficacy and tolerabil...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2008-04-30
Trial ID
NCT00699972
Treatments Being Tested
The purpose of this study is to confirm the efficacy and safety of perampan...
Status
Completed
Location
Facility #1
Start Date
2012-05-15
Trial ID
NCT01618695
Treatments Being Tested
The Extended Access Program (EAP) is a managed access programme for Perampa...
Status
No Longer Available
Location
Fundacion Cerebro Y Mente
Start Date
TBD
Trial ID
NCT01871233
Treatments Being Tested
This study is designed to investigate the short- and long-term effects of p...
Status
Completed
Location
Multiple Locations
Start Date
2010-09
Trial ID
NCT01161524
Treatments Being Tested
This study will be conducted to evaluate the bioavailability of a single 12...
Status
Completed
Location
Anaheim Clinical Trials
Start Date
2017-11-08
Trial ID
NCT03376997
Treatments Being Tested
The purpose of this study is to determine the efficacy and safety of Peramp...
Status
Completed
Location
Dr. Richard Blonsky
Start Date
2007-06
Trial ID
NCT00505284
Treatments Being Tested
This study is conducted to evaluate the seizure-free rate of the 26-week Ma...
Status
Completed
Location
Eisai Trial Site #18
Start Date
2017-06-28
Trial ID
NCT03201900
Treatments Being Tested